Form EFFECT Akari Therapeutics Plc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 31, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdIndex Publishes Updated European Peer-to-Peer Lending Default and Recovery Barometer Revealing Wide Disclosure Gaps
- Tzokamirel Reviews: Why Traders Are Talking About Tzokamirel AI Platform
- Broken Yolk Cafe Named "Best Breakfast" and "Best Brunch" In Readers' Poll
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
